Peptide-Conjugated Quantum Dots Activate Neuronal Receptors and Initiate Downstream Signaling of Neurite Growth
- 24 March 2005
- journal article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 5 (4), 603-607
- https://doi.org/10.1021/nl047977c
Abstract
Quantum dots (QDs) could serve as fluorescent scaffolds for effecting specific physiological and pharmacological responses in cells. Here, we conjugate the peptide ligand betaNGF to QD surfaces, and confirm surface modification and single QD nanostructure using AFM. We show that betaNGF-QDs retain bioactivity, activate TrkA receptors, and initiate neuronal differentiation in PC12 cells. Receptor-evoked activity of QD-immobilized ligands has wide-ranging implications for the development of molecular tools and therapeutics targeted at understanding and regulating cell function.Keywords
This publication has 13 references indexed in Scilit:
- Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transductionNature Biotechnology, 2004
- The use of nanocrystals in biological detectionNature Biotechnology, 2003
- Signaling Pathways for PC12 Cell Differentiation: Making the Right ConnectionsScience, 2002
- Targeting Cell Surface Receptors with Ligand-Conjugated NanocrystalsJournal of the American Chemical Society, 2002
- Neurotrophins: Roles in Neuronal Development and FunctionAnnual Review of Neuroscience, 2001
- Nerve Growth Factor Signaling, Neuroprotection, and Neural RepairAnnual Review of Neuroscience, 2001
- Protein Tyrosine Kinase Structure and FunctionAnnual Review of Biochemistry, 2000
- Semiconductor Nanocrystals as Fluorescent Biological LabelsScience, 1998
- Receptor Binding Activities of Biotinylated Derivatives of β‐Nerve Growth FactorJournal of Neurochemistry, 1986
- Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.Proceedings of the National Academy of Sciences, 1976